Nomenclature
CAS number: 144412-49-7
(
S)-[[1-[2-[[4-(Aminoiminomethyl)benzoyl]amino]-3-(4-hydroxyphenyl)-1-oxopropyl]-4-piperidinyl]oxy]acetic
acid; [[1-[
N-(
p-amidinobenzoyl)-
l-tyrosyl]-4-piperidinyl]oxy]acetic
acid; Ro-44-9883.
C
24H
28N
4O
6; mol wt 468.50.
C 61.53%, H 6.02%, N 11.96%, O 20.49%.
Description and references
Specific nonpeptide platelet fibrinogen receptor
(GPIIb/IIIa) antagonist. Prepn: L. Alig et al., EP 505868; eidem, US 5378712 (1992, 1995 both to Hoffmann-La Roche); L. Alig et al., J. Med. Chem. 35, 4393 (1992). Pharmacology: J.-P. Carteaux et al., Thromb. Haemostasis 70, 817 (1993); Y. Takiguchi et al., ibid. 73, 683 (1995).
Properties
Crystals (zwitterionic form) from water, mp above 200° (dec).
[α]D20 +29.8° (c = 0.86 in 1N HCl).Derivative
Trifluoroacetate salt.
Nomenclature
CAS number: 144412-50-0
C
24H
28N
4O
6.C
2HF
3O
2; mol wt 582.53.
C 53.61%, H 5.02%, N 9.62%, O 21.97%, F 9.78%.
Properties
mp 125-130° (dec). LD50 i.v. in mice: 250 mg/kg (Alig, 1995).Therapeutic Category
Antithrombotic.
Keywords
Antithrombotic; Fibrinogen Receptor Antagonist